The suit, which includes multiple accusations of malpractice and dishonest behavior, is just the latest chapter of a story that has been making headlines for years. 

ShortCut, which gained the FDA’s breakthrough device designation back in January, is used to split valve leaflets and reduce the risk of obstruction.

Cardiac ablation techniques and technologies are constantly evolving. Only well-trained specialists should be performing these procedures, the Heart Rhythm Society said in a new policy statement.

The news comes just one day before HFSA 2024 was scheduled to begin. HFSA is already considering the possibility of virtual sessions, but its primary concern is the safety of attendees. 

Patient lifestyles represent a significant challenge when treating and managing heart patients, according to a survey of more than 400 cardiologists. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

California-based Route 92 Medical previously announced a funding round worth more than $31 million in November. Now, however, a massive addition from Novo Holdings makes the round worth closer to $82 million.